Pelargonium sidoides (EPs 7630) was reported to benefit both adults and children with acute bronchitis without indication for treatment with antibiotics. A total of 2099 patients aged 0-93 years were included in this study. Participants received EPs 7630 for 14 days at a dose determined by a participant\’s age. The doses provided included the following. The dose was given 30 minutes before meals. Adults and children over 12 years were given a dose of 30 drops, children over 6 up to 12 years old were provided a dose of 20 drops, and children under 6 years old were given 10 drops per dose. During treatment, the average Bronchitis Severity Score (BSS: cough, sputum, rales/rhonchi, chest pain at cough, dyspnea) of all patients decreased from 7.1 points at baseline to 1.0 points at last visit. For children, average BSS decreased from 6.3 points to 0.9 points. For children aged 3 years or less, average mean BSS decresed from 5.2 points to 1.2 points. No serious side-effects were reported. (2)
